Clinical trial NCT00591474 - References

GI Colonization of Vancomycin-resistant Enterococcus — The Influence of Probiotics on Vancomycin-Resistant Enterococcus

Citation(s)

•   Alvarez-Olmos MI, Oberhelman RA
  Probiotic agents and infectious diseases: a modern perspective on a traditional therapy. Clin Infect Dis. 2001 Jun 1;32(11):1567-76. Epub 2001 May 4. Review.
•   Baden LR, Thiemke W, Skolnik A, Chambers R, Strymish J, Gold HS, Moellering RC Jr, Eliopoulos GM
  Prolonged colonization with vancomycin-resistant Enterococcus faecium in long-term care patients and the significance of "clearance". Clin Infect Dis. 2001 Nov 15;33(10):1654-60. Epub 2001 Oct 10.
•   Borriello SP, Hammes WP, Holzapfel W, Marteau P, Schrezenmeir J, Vaara M, Valtonen V
  Safety of probiotics that contain lactobacilli or bifidobacteria. Clin Infect Dis. 2003 Mar 15;36(6):775-80. Epub 2003 Mar 5. Review.
•   Bryce EA, Tiffin SM, Isaac-Renton JL, Wright CJ
  Evidence of delays in transferring patients with methicillin-resistant Staphylococcus aureus or vancomycin-resistant Enterococcus to long-term-care facilities. Infect Control Hosp Epidemiol. 2000 Apr;21(4):270-1.
•   Carmeli Y, Eliopoulos G, Mozaffari E, Samore M
  Health and economic outcomes of vancomycin-resistant enterococci. Arch Intern Med. 2002 Oct 28;162(19):2223-8.
•   De Groote MA, Frank DN, Dowell E, Glode MP, Pace NR
  Lactobacillus rhamnosus GG bacteremia associated with probiotic use in a child with short gut syndrome. Pediatr Infect Dis J. 2005 Mar;24(3):278-80.
•   Delia P, Sansotta G, Donato V, Messina G, Frosina P, Pergolizzi S, De Renzis C, Famularo G
  Prevention of radiation-induced diarrhea with the use of VSL#3, a new high-potency probiotic preparation. Am J Gastroenterol. 2002 Aug;97(8):2150-2.
•   Dunne C
  Adaptation of bacteria to the intestinal niche: probiotics and gut disorder. Inflamm Bowel Dis. 2001 May;7(2):136-45. Review.
•   Gorbach SL
  Probiotics and gastrointestinal health. Am J Gastroenterol. 2000 Jan;95(1 Suppl):S2-4.
•   Harbarth S, Cosgrove S, Carmeli Y
  Effects of antibiotics on nosocomial epidemiology of vancomycin-resistant enterococci. Antimicrob Agents Chemother. 2002 Jun;46(6):1619-28. Review.
•   Hendrix CW, Hammond JM, Swoboda SM, Merz WG, Harrington SM, Perl TM, Dick JD, Borschel DM, Halczenko PW, Pelz RK, Rocco LE, Conway JE, Brower RG, Lipsett PA
  Surveillance strategies and impact of vancomycin-resistant enterococcal colonization and infection in critically ill patients. Ann Surg. 2001 Feb;233(2):259-65.
•   Hickson M, D'Souza AL, Muthu N, Rogers TR, Want S, Rajkumar C, Bulpitt CJ
  Use of probiotic Lactobacillus preparation to prevent diarrhoea associated with antibiotics: randomised double blind placebo controlled trial. BMJ. 2007 Jul 14;335(7610):80. Epub 2007 Jun 29.
•   Humphreys H, Dolan V, Sexton T, Conlon P, Rajan L, Creamer E, Walshe J, Donohoe J, Smyth EG
  Implications of colonization of vancomycin-resistant enterococci (VRE) in renal dialysis patients. Learning to live with it? J Hosp Infect. 2004 Sep;58(1):28-33.
•   Joels CS, Matthews BD, Sigmon LB, Hasan R, Lohr CE, Kercher KW, Norton J, Sing RF, Heniford BT
  Clinical characteristics and outcomes of surgical patients with vancomycin-resistant enterococcal infections. Am Surg. 2003 Jun;69(6):514-9.
•   Klare I, Konstabel C, Werner G, Huys G, Vankerckhoven V, Kahlmeter G, Hildebrandt B, Müller-Bertling S, Witte W, Goossens H
  Antimicrobial susceptibilities of Lactobacillus, Pediococcus and Lactococcus human isolates and cultures intended for probiotic or nutritional use. J Antimicrob Chemother. 2007 May;59(5):900-12. Epub 2007 Mar 16.
•   Kreman T, Hu J, Pottinger J, Herwaldt LA
  Survey of long-term-care facilities in Iowa for policies and practices regarding residents with methicillin-resistant Staphylococcus aureus or vancomycin-resistant enterococci. Infect Control Hosp Epidemiol. 2005 Oct;26(10):811-5.
•   Kunz AN, Noel JM, Fairchok MP
  Two cases of Lactobacillus bacteremia during probiotic treatment of short gut syndrome. J Pediatr Gastroenterol Nutr. 2004 Apr;38(4):457-8.
•   Land MH, Rouster-Stevens K, Woods CR, Cannon ML, Cnota J, Shetty AK
  Lactobacillus sepsis associated with probiotic therapy. Pediatrics. 2005 Jan;115(1):178-81.
•   Mackay AD, Taylor MB, Kibbler CC, Hamilton-Miller JM
  Lactobacillus endocarditis caused by a probiotic organism. Clin Microbiol Infect. 1999 May;5(5):290-292.
•   Manley KJ, Fraenkel MB, Mayall BC, Power DA
  Probiotic treatment of vancomycin-resistant enterococci: a randomised controlled trial. Med J Aust. 2007 May 7;186(9):454-7.
•   Matar MJ, Tarrand J, Raad I, Rolston KV
  Colonization and infection with vancomycin-resistant Enterococcus among patients with cancer. Am J Infect Control. 2006 Oct;34(8):534-6.
•   McFarland LV
  Meta-analysis of probiotics for the prevention of antibiotic associated diarrhea and the treatment of Clostridium difficile disease. Am J Gastroenterol. 2006 Apr;101(4):812-22.
•   Montecalvo MA, de Lencastre H, Carraher M, Gedris C, Chung M, VanHorn K, Wormser GP
  Natural history of colonization with vancomycin-resistant Enterococcus faecium. Infect Control Hosp Epidemiol. 1995 Dec;16(12):680-5.
•   National Nosocomial Infections Surveillance System
  National Nosocomial Infections Surveillance (NNIS) System Report, data summary from January 1992 through June 2004, issued October 2004. Am J Infect Control. 2004 Dec;32(8):470-85.
•   Osterlund P, Ruotsalainen T, Korpela R, Saxelin M, Ollus A, Valta P, Kouri M, Elomaa I, Joensuu H
  Lactobacillus supplementation for diarrhoea related to chemotherapy of colorectal cancer: a randomised study. Br J Cancer. 2007 Oct 22;97(8):1028-34. Epub 2007 Sep 25.
•   Patel R, Allen SL, Manahan JM, Wright AJ, Krom RA, Wiesner RH, Persing DH, Cockerill FR, Thompson RL
  Natural history of vancomycin-resistant enterococcal colonization in liver and kidney transplant recipients. Liver Transpl. 2001 Jan;7(1):27-31.
•   Patel R
  Clinical impact of vancomycin-resistant enterococci. J Antimicrob Chemother. 2003 Jun;51 Suppl 3:iii13-21. Review.
•   Pelz RK, Lipsett PA, Swoboda SM, Diener-West M, Powe NR, Brower RG, Perl TM, Hammond JM, Hendrix CW
  Vancomycin-sensitive and vancomycin-resistant enterococcal infections in the ICU: attributable costs and outcomes. Intensive Care Med. 2002 Jun;28(6):692-7. Epub 2002 Apr 12.
•   Rautio M, Jousimies-Somer H, Kauma H, Pietarinen I, Saxelin M, Tynkkynen S, Koskela M
  Liver abscess due to a Lactobacillus rhamnosus strain indistinguishable from L. rhamnosus strain GG. Clin Infect Dis. 1999 May;28(5):1159-60.
•   Rayes N, Seehofer D, Hansen S, Boucsein K, Müller AR, Serke S, Bengmark S, Neuhaus P
  Early enteral supply of lactobacillus and fiber versus selective bowel decontamination: a controlled trial in liver transplant recipients. Transplantation. 2002 Jul 15;74(1):123-7.
•   Rayes N, Seehofer D, Theruvath T, Schiller RA, Langrehr JM, Jonas S, Bengmark S, Neuhaus P
  Supply of pre- and probiotics reduces bacterial infection rates after liver transplantation--a randomized, double-blind trial. Am J Transplant. 2005 Jan;5(1):125-30.
•   Roghmann MC, Qaiyumi S, Schwalbe R, Morris JG Jr
  Natural history of colonization with vancomycin-resistant Enterococcus faecium. Infect Control Hosp Epidemiol. 1997 Oct;18(10):679-80.
•   Sartor RB
  Probiotic therapy of intestinal inflammation and infections. Curr Opin Gastroenterol. 2005 Jan;21(1):44-50. Review.
•   Saxelin M, Chuang NH, Chassy B, Rautelin H, Mäkelä PH, Salminen S, Gorbach SL
  Lactobacilli and bacteremia in southern Finland, 1989-1992. Clin Infect Dis. 1996 Mar;22(3):564-6.
•   Vanderhoof JA, Whitney DB, Antonson DL, Hanner TL, Lupo JV, Young RJ
  Lactobacillus GG in the prevention of antibiotic-associated diarrhea in children. J Pediatr. 1999 Nov;135(5):564-8.
•   Vanderhoof JA, Young RJ
  Current and potential uses of probiotics. Ann Allergy Asthma Immunol. 2004 Nov;93(5 Suppl 3):S33-7. Review.
•   Vanderhoof JA
  Probiotics: future directions. Am J Clin Nutr. 2001 Jun;73(6):1152S-1155S. Review.
•   Weinstock DM, Conlon M, Iovino C, Aubrey T, Gudiol C, Riedel E, Young JW, Kiehn TE, Zuccotti G
  Colonization, bloodstream infection, and mortality caused by vancomycin-resistant enterococcus early after allogeneic hematopoietic stem cell transplant. Biol Blood Marrow Transplant. 2007 May;13(5):615-21. Epub 2007 Mar 23.
•   Zaas AK, Song X, Tucker P, Perl TM
  Risk factors for development of vancomycin-resistant enterococcal bloodstream infection in patients with cancer who are colonized with vancomycin-resistant enterococci. Clin Infect Dis. 2002 Nov 15;35(10):1139-46. Epub 2002 Oct 17.
•   Zirakzadeh A, Patel R
  Vancomycin-resistant enterococci: colonization, infection, detection, and treatment. Mayo Clin Proc. 2006 Apr;81(4):529-36. Review.

The Influence of Probiotics on Vancomycin-Resistant Enterococcus

Details for clinical trial NCT00591474